The prognostic and predictive value of serum CA19.9 in pancreatic cancer

BACKGROUND: Current staging methods for pancreatic cancer (PC) are inadequate, and biomarkers to aid clinical decision making are lacking. Despite the availability of the serum marker carbohydrate antigen 19.9 (CA19.9) for over two decades, its precise role in the management of PC is yet to be defin...

Descripción completa

Detalles Bibliográficos
Autores principales: Humphris, J. L., Chang, D. K., Johns, A. L., Scarlett, C. J., Pajic, M., Jones, M. D., Colvin, E. K., Nagrial, A., Chin, V. T., Chantrill, L. A., Samra, J. S., Gill, A. J., Kench, J. G., Merrett, N. D., Das, A., Musgrove, E. A., Sutherland, R. L., Biankin, A. V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2012
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3387824/
https://www.ncbi.nlm.nih.gov/pubmed/22241899
http://dx.doi.org/10.1093/annonc/mdr561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3387824/
https://www.ncbi.nlm.nih.gov/pubmed/22241899
http://dx.doi.org/10.1093/annonc/mdr561

Ejemplares similares